We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Download Mobile App

Newly-Launched Portable Molecular Diagnostic Platform Detects COVID-19 at Point-of-Care within 30 Minutes

By LabMedica International staff writers
Posted on 15 Oct 2021
Print article
Image: The PEBBLE qcLAMP Platform (Photo courtesy of BIOPIX-T)
Image: The PEBBLE qcLAMP Platform (Photo courtesy of BIOPIX-T)

A new portable molecular diagnostic platform and its compatible diagnostic test for the detection of SARS-CoV-2 delivers results within 30 minutes at the Point-of-Care (POC).

BIOPIX-T (Voutes, Greece) has launched its portable molecular diagnostic platform, the PEBBLE qcLAMP Platform, along with its compatible diagnostic test for the detection of the SARS-CoV-2 virus. PEBBLE is the first Greek portable molecular diagnostic device based on LAMP technology (Isothermal PCR), which can be used at the POC. PEBBLE as well as COV19 qcLAMP kit, the corresponding diagnostic kit to be used together with the diagnostic instrument for the detection of SARS-CoV-2, are now CE Marked.

The reliability of the PEBBLE device is comparable to the corresponding laboratory ‘reference devices’, which cost nevertheless tens of times more and cannot be transported to the points of interest. This offers to the responsible authorities an excellent new weapon for management of the pandemic as they will be able to perform rapid (within 30 minutes) and much more reliable molecular tests at a cost comparable to that of rapid tests. Other innovative features of the device are expected to be gradually certified and utilized, such as the ability to perform tests on a saliva sample, without the unpleasant current sampling procedure.

“BIOPIX-T’s innovative molecular diagnostic device can be a catalyst, giving a very fast, cost-effective and at the same time reliable result to all points of care as well as other points of interest, such as airports, cruise ships, companies, community services, but also hotels, border entry points or immigration hot-spots, etc.,” said George Papadakis who leads BIOPIX-T.

Related Links:

Gold Supplier
Undercounter Laboratory Refrigerator
Auto Multiparameter POC Analyzer
Triage MeterPro
Gold Supplier
TBI Blood Test
i-STAT TBI Plasma Test

Print article


Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more


view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more


view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more


view channel

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.